Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Gains from Investment Securities: 2020-2025

Historic Gains from Investment Securities for Sotera Health (SHC) over the last 4 years, with Sep 2025 value amounting to $15.4 million.

  • Sotera Health's Gains from Investment Securities rose 4.53% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.0 million, marking a year-over-year increase of 41.78%. This contributed to the annual value of $65.8 million for FY2024, which is 31.11% up from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Gains from Investment Securities is $15.4 million, which was down 22.97% from $20.0 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Gains from Investment Securities registered a high of $23.4 million during Q4 2024, and its lowest value of $7.6 million during Q4 2023.
  • In the last 3 years, Sotera Health's Gains from Investment Securities had a median value of $14.7 million in 2024 and averaged $15.0 million.
  • Per our database at Business Quant, Sotera Health's Gains from Investment Securities spiked by 401.34% in 2021 and then tumbled by 59.93% in 2023.
  • Sotera Health's Gains from Investment Securities (Quarterly) stood at $20.1 million in 2021, then declined by 5.29% to $19.0 million in 2022, then slumped by 59.93% to $7.6 million in 2023, then skyrocketed by 206.73% to $23.4 million in 2024, then rose by 4.53% to $15.4 million in 2025.
  • Its Gains from Investment Securities was $15.4 million in Q3 2025, compared to $20.0 million in Q2 2025 and $12.2 million in Q1 2025.